Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Samsung Biologics signs manufacturing deal with European pharmaceutical company
2024-11-20 07:23
Samsung Biologics earns ISO certifications in recognition of business excellence
2024-11-08 20:00
Samsung Biologics reports third quarter 2024 financial results
2024-10-23 14:55
Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development
2024-10-14 19:00
Samsung Biologics launches development platforms for enhanced therapeutic efficacy
2024-09-25 19:00
Samsung Biologics joins the Pharmaceutical Supply Chain Initiative as Supplier Partner
2024-08-06 19:00
Samsung Biologics Reports First Quarter 2024 Financial Results
2024-04-24 14:45
Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance
2023-09-18 07:57
Samsung Biologics appoints new leadership to oversee quality and regulatory affairs
2023-08-24 07:59
Samsung Biologics Reports Second Quarter 2023 Financial Results
2023-07-26 15:23
Samsung Biologics releases 2023 ESG Report, reaffirming its commitment to net-zero progress and corporate social responsibility
2023-07-18 19:00
Samsung Biologics accelerates timeline of new fifth plant to be operational by April 2025
2023-06-06 19:00
Samsung Biologics Reports First Quarter 2023 Financial Results
2023-04-24 14:51
Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion
2023-03-17 19:25
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results
2023-01-27 14:52
Samsung Biologics receives the Terra Carta Seal in recognition of the company's commitment to creating a sustainable future
2023-01-11 08:01
Samsung Biologics Reports Third Quarter 2022 Financial Results
2022-10-27 07:35
Samsung Biologics obtains three global ISO certifications
2022-10-13 19:00
Samsung Biologics unlocks additional capacity for production at its newest Plant 4
2022-10-11 19:00
Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022
2022-09-29 19:00
1
2
3
4
5